-
Biotech Partners on Synthetic Proteins to Protect Crops
A developer of synthetic antibody-like proteins for protecting crops is collaborating with a global agricultural chemical company on sustainable biologic insect controls.
-
Infographic – Major A.I. Work Impact Expected
22 Apr. 2023. In a recent poll, most Americans expect artificial intelligence to have a major impact on the conduct of work in the next 20 years, but not their own work. Pew Research Center released the findings of the survey on Thursday 20 Apr., conducted in Dec. 2022 among adults in the U.S. The…
-
Biotech Gains $53.7M Infectious Disease Test Award
A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections.
-
Trial Shows Plant-Based Drug Helps Reduce Vaping
First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco.
-
Biotech, Undersea Researchers Partner on Carbon Capture Bacteria
A microbiome biotechnology company and an undersea research group are studying microorganisms that thrive in and consume intense carbon dioxide.
-
New Funds to Invest in Digital Health Start-Ups
A venture capital company supporting developers of digital technologies in health care says it raised $460 million to invest in early-stage digital health businesses.
-
Taking a Break
We’ll resume our regular posts on Tuesday, 18 Apr.
-
Biotech, Dairy Company Collaborate on Plant-Based Cheese
A maker of consumer dairy products and biotechnology food start-up are partnering on plant-based cheeses they say are indistinguishable from today’s dairy cheese.
-
Cancer Cell Therapy Biotech Launches, Raises $10M
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds.
-
Biotech Group Blasts Reproductive Drug Ruling
A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.”